General Information of Disease (ID: DIS9DIA4)

Disease Name Cardiac arrest
Synonyms circulatory arrest; cardiopulmonary arrest
Disease Class MC82: Cardiac arrest
Definition Cessation of breathing and/or cardiac function.
Disease Hierarchy
DIS1W8PP: Tachyarrhythmias
DIS9DIA4: Cardiac arrest
ICD Code
ICD-11
ICD-11: MC82
Expand ICD-11
'MC82
Expand ICD-10
'I46; 'I46.0; 'I46.1; 'I46.9
Disease Identifiers
MONDO ID
MONDO_0000745
MESH ID
D006323
UMLS CUI
C0018790
MedGen ID
5456
HPO ID
HP:0001695
SNOMED CT ID
397829000

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 5 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Calcium Acetate DM40MBV Approved Small molecular drug [1]
Calcium Chloride DMYVFR3 Approved Small molecular drug [2]
Calcium Gluceptate DM05ZXO Approved Small molecular drug [3]
Isoproterenol DMK7MEY Approved Small molecular drug [4]
Metoprolol DMOJ0V6 Approved Small molecular drug [5]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Neu-2000 DMNJTLC Phase 1 NA [6]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 3 Preclinical Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Beta-aminopropionitrile DMSJ2I6 Preclinical Small molecular drug [7]
CA-074Me DMVN3FU Preclinical Small molecular drug [7]
SHP-627 DMHAONP Preclinical Small molecular drug [7]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 1 Investigative Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
PD98059 DMZC90M Investigative Small molecular drug [8]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 46 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
BCL11A TTR61MW Limited Biomarker [9]
HBB TTM6HK1 Limited Genetic Variation [10]
ITPR1 TT5HWAT Limited Genetic Variation [11]
KCNQ1 TT846HF Limited Genetic Variation [12]
OAT TTTSCQ2 Limited Genetic Variation [13]
POR TTOQ9GZ Limited Genetic Variation [14]
SERPIND1 TT8XSKJ Limited Altered Expression [15]
SLCO1A2 TTUGD21 Limited Genetic Variation [16]
INS TTZOPHG moderate Therapeutic [17]
PRKCG TTRFOXJ moderate Altered Expression [18]
ABCC8 TTP835K Strong Altered Expression [19]
ACLY TT0Z6Y2 Strong Biomarker [20]
ANGPTL3 TT59GO7 Strong Biomarker [21]
ASIC1 TTRJYB6 Strong Biomarker [22]
AVPR1B TTL9MHW Strong Altered Expression [23]
AVPR2 TTK8R02 Strong Biomarker [24]
CACNA1C TTZIFHC Strong Genetic Variation [25]
CACNA1G TT729IR Strong Genetic Variation [26]
CCL5 TT9DWLC Strong Biomarker [27]
CDC7 TTSMTDI Strong Altered Expression [28]
CYP46A1 TT4EB85 Strong Biomarker [29]
FPR1 TT5Y4EM Strong Biomarker [30]
G6PD TTKN8W0 Strong Biomarker [31]
GFAP TTI6FFX Strong Biomarker [32]
HBA2 TTQO71U Strong Genetic Variation [33]
HCRT TTU5HJP Strong Altered Expression [34]
HTR1E TTCPG9S Strong Biomarker [35]
IL18 TTRICUF Strong Genetic Variation [36]
ITPR3 TTH1769 Strong Altered Expression [37]
KCND3 TTPLQO0 Strong Genetic Variation [38]
KCNH2 TTQ6VDM Strong Genetic Variation [39]
KCNJ2 TTH7UO3 Strong Genetic Variation [40]
LTC4S TTW7OTG Strong Genetic Variation [41]
MASP2 TTR01E9 Strong Altered Expression [42]
MYB TT8V13P Strong Biomarker [43]
OSCAR TT71Q5Y Strong Biomarker [44]
PLA2R1 TTHKW7D Strong Biomarker [45]
SCN5A TTZOVE0 Strong Genetic Variation [46]
SLC25A4 TTU5A6Q Strong Biomarker [47]
SSTR1 TTIND6G Strong Biomarker [48]
SSTR5 TT2BC4G Strong Biomarker [48]
TNF TTF8CQI Strong Biomarker [49]
TNNI3 TTNLDK6 Strong Biomarker [50]
TRPM4 TTJ2HKA Strong Altered Expression [19]
UGCG TTPHEX3 Strong Genetic Variation [51]
UGT1A1 TT34ZAF Strong Genetic Variation [52]
------------------------------------------------------------------------------------
⏷ Show the Full List of 46 DTT(s)
This Disease Is Related to 3 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SLC4A3 DT4X2AH moderate Biomarker [53]
SLC25A6 DTLMGFJ Strong Biomarker [47]
SLC7A7 DTE4HJ8 Strong Biomarker [54]
------------------------------------------------------------------------------------
This Disease Is Related to 10 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
ACSS2 DEE76VW Strong Biomarker [55]
ADH5 DEIOH6A Strong Biomarker [56]
FXN DEXVHDB Strong Biomarker [57]
TGM6 DEUWCVD Strong Genetic Variation [58]
UBASH3B DE10BJ5 Strong Biomarker [59]
UGT1A10 DEL5N6Y Strong Genetic Variation [60]
UGT1A4 DELOY3P Strong Genetic Variation [60]
UGT1A6 DESD26P Strong Genetic Variation [60]
UGT1A7 DEZO4N3 Strong Genetic Variation [60]
UGT1A8 DE2GB8N Strong Genetic Variation [60]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 DME(s)
This Disease Is Related to 61 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ADCY6 OTFOY4WW Limited Genetic Variation [61]
CPLANE1 OTXGGNNB Limited Biomarker [62]
ENO2 OTRODL0T Limited Biomarker [63]
TBP OT6C0S52 Limited Genetic Variation [64]
ATXN7 OTL3YF1H Disputed Biomarker [65]
DYNLL1 OTR69LHT moderate Biomarker [66]
ELOVL4 OT2M9W26 moderate Genetic Variation [67]
LUC7L3 OTKDED8A moderate Biomarker [68]
MTMR11 OTHL2O08 moderate Biomarker [68]
PRKAG2 OTHTAM54 moderate Genetic Variation [69]
ACCS OTHIHI9D Strong Biomarker [55]
AFG3L2 OTRPMAUX Strong Genetic Variation [70]
AGBL2 OTCX9987 Strong Biomarker [71]
ATN1 OTNZFLKY Strong Biomarker [72]
ATP1A3 OTM8EG6H Strong Genetic Variation [73]
ATXN10 OTKRDUNN Strong Biomarker [74]
BTBD8 OT3A3RD7 Strong Biomarker [75]
CALM2 OTNYA92F Strong Genetic Variation [76]
CAPS OTC9GZ2M Strong Genetic Variation [77]
CASQ2 OT09MNQ8 Strong Genetic Variation [78]
DAB1 OTPL9MA3 Strong Genetic Variation [79]
ELOVL5 OT375W1Z Strong Genetic Variation [80]
ERBIN OTNWTUA8 Strong Genetic Variation [81]
FAN1 OT1LM1HZ Strong Genetic Variation [82]
GPC5 OT8NR7GC Strong Genetic Variation [40]
HBA1 OTW2BQF4 Strong Genetic Variation [33]
HBG1 OTVL4NSU Strong Altered Expression [83]
HBG2 OT4J48JJ Strong Biomarker [84]
HBS1L OTA3U1N6 Strong Genetic Variation [85]
IGFALS OTTWCZYM Strong Genetic Variation [86]
KCND2 OTIFUVV7 Strong Genetic Variation [87]
KCNE1 OTZNQUW9 Strong Genetic Variation [88]
LPCAT1 OTCV7AGV Strong Biomarker [89]
MIPEP OTB2IHCT Strong Genetic Variation [90]
MLC1 OTCNZLSP Strong Biomarker [91]
MTSS1 OT5DTDO2 Strong Biomarker [92]
NEFL OTQESJV4 Strong Altered Expression [93]
NHS OTKE8QAT Strong Biomarker [94]
NLK OT2LETFS Strong Altered Expression [95]
NOP56 OTT67SRZ Strong Biomarker [96]
NOS1AP OTDFOBRU Strong Genetic Variation [12]
OR2AG1 OTEITRP4 Strong Genetic Variation [97]
PDYN OTEJ6430 Strong Genetic Variation [98]
PHLPP1 OTIFXW8D Strong Altered Expression [99]
PLA2G15 OT6VJTPA Strong Biomarker [55]
PLEKHG4 OT3RBPFL Strong Genetic Variation [100]
PPA2 OTRKV8WW Strong Genetic Variation [101]
PPP1R15A OTYG179K Strong Altered Expression [102]
PPP2R2B OTSFVC82 Strong Genetic Variation [103]
RAN OT2TER5M Strong Biomarker [104]
RAPGEF5 OT53VS75 Strong Genetic Variation [105]
RHBDF1 OTCQ7UDS Strong Biomarker [106]
SEMA3F OTQFMS8S Strong Biomarker [107]
SLITRK1 OT1QQ7FR Strong Biomarker [108]
SPTBN2 OTDMJ75N Strong Genetic Variation [109]
SS18L1 OT9ZEGV7 Strong Biomarker [110]
STUB1 OTSUYI9A Strong Genetic Variation [111]
SYN1 OTMNPWC1 Strong Genetic Variation [112]
TBX19 OTXEMR2U Strong Altered Expression [23]
TRDN OTXVE9SF Strong Genetic Variation [113]
TTBK2 OT90YSM5 Strong Genetic Variation [114]
------------------------------------------------------------------------------------
⏷ Show the Full List of 61 DOT(s)

References

1 Calcium Acetate FDA Label
2 Calcium Chloride FDA Label
3 Calcium Gluceptate FDA Label
4 Isoproterenol FDA Label
5 Metoprolol FDA Label
6 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025797)
7 Drugs and Targets in Fibrosis. Front Pharmacol. 2017 Nov 23;8:855.
8 PD98059 protects the brain against mitochondrial-mediated apoptosis and autophagy in a cardiac arrest rat model. Life Sci. 2019 Sep 1;232:116618.
9 Sickle Cell Anemia and Its Phenotypes.Annu Rev Genomics Hum Genet. 2018 Aug 31;19:113-147. doi: 10.1146/annurev-genom-083117-021320. Epub 2018 Apr 11.
10 Insight into the complex pathophysiology of sickle cell anaemia and possible treatment.Eur J Haematol. 2019 Apr;102(4):319-330. doi: 10.1111/ejh.13212. Epub 2019 Feb 21.
11 Ca(2+) signaling and spinocerebellar ataxia.Biochim Biophys Acta Mol Cell Res. 2018 Nov;1865(11 Pt B):1733-1744. doi: 10.1016/j.bbamcr.2018.05.009. Epub 2018 May 16.
12 Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population.Stem Cell Res. 2019 Aug;39:101510. doi: 10.1016/j.scr.2019.101510. Epub 2019 Jul 24.
13 Lymphocyte subpopulations in homozygous sickle cell anaemia.Acta Haematol. 1985;74(1):10-3. doi: 10.1159/000206155.
14 CaRdiac Arrest Survival Score (CRASS) - A tool to predict good neurological outcome after out-of-hospital cardiac arrest.Resuscitation. 2020 Jan 1;146:66-73. doi: 10.1016/j.resuscitation.2019.10.036. Epub 2019 Nov 12.
15 Effect of a Congolese herbal medicine used in sickle cell anemia on the expression of plasminogen activators in human coronary aortic endothelial cells culture.J Ethnopharmacol. 2013 Mar 27;146(2):594-9. doi: 10.1016/j.jep.2013.01.031. Epub 2013 Jan 30.
16 Genetic link with cholelithiasis among pediatric SCA Tunisian patients: Examples of UGT1A1, SLCO1A2 and SLCO1B1.Hematology. 2016 Mar;21(2):121-5. doi: 10.1179/1607845415Y.0000000030. Epub 2015 Jul 6.
17 The hemodynamic effects of insulin following overdosage with levobupivacaine or racemic bupivacaine in dogs.J Korean Med Sci. 2007 Apr;22(2):342-6. doi: 10.3346/jkms.2007.22.2.342.
18 Increased protein kinase C gamma activity induces Purkinje cell pathology in a mouse model of spinocerebellar ataxia 14.Neurobiol Dis. 2014 Oct;70:1-11. doi: 10.1016/j.nbd.2014.06.002. Epub 2014 Jun 14.
19 Glibenclamide and Therapeutic Hypothermia Have Comparable Effect on Attenuating Global Cerebral Edema Following Experimental Cardiac Arrest.Neurocrit Care. 2018 Aug;29(1):119-127. doi: 10.1007/s12028-017-0479-3.
20 The reduced concentration of citrate in cancer cells: An indicator of cancer aggressiveness and a possible therapeutic target.Drug Resist Updat. 2016 Nov;29:47-53. doi: 10.1016/j.drup.2016.09.003. Epub 2016 Sep 21.
21 Hypocholesterolemia and dysregulated production of angiopoietin-like proteins in sickle cell anemia patients.Cytokine. 2019 Aug;120:88-91. doi: 10.1016/j.cyto.2019.04.014. Epub 2019 May 1.
22 Amiloride Alleviates Neurological Deficits Following Transient Global Ischemia and Engagement of Central IL-6 and TNF- Signal.Curr Mol Med. 2019;19(8):597-604. doi: 10.2174/1566524019666190704100444.
23 Differential gene expression in ACTH -secreting and non-functioning pituitary tumors.Eur J Endocrinol. 2007 Dec;157(6):717-24. doi: 10.1530/EJE-07-0428.
24 Mitochondrial tRNALeu/Lys and ATPase 6/8 gene variations in spinocerebellar ataxias.Neurodegener Dis. 2009;6(1-2):16-22. doi: 10.1159/000170885. Epub 2008 Nov 5.
25 Penetrance and expressivity of the R858H CACNA1C variant in a five-generation pedigree segregating an arrhythmogenic channelopathy.Mol Genet Genomic Med. 2019 Jan;7(1):e00476. doi: 10.1002/mgg3.476. Epub 2018 Oct 21.
26 A case of a novel CACNA1G mutation from a Chinese family with SCA42: A case report and literature review.Medicine (Baltimore). 2018 Sep;97(36):e12148. doi: 10.1097/MD.0000000000012148.
27 Periapical cytokine expression in sickle cell disease.J Endod. 2015 Mar;41(3):358-62. doi: 10.1016/j.joen.2014.11.016. Epub 2015 Jan 6.
28 Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53-mutant breast cancers.Am J Pathol. 2010 Oct;177(4):2034-45. doi: 10.2353/ajpath.2010.100421. Epub 2010 Aug 19.
29 Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia.Acta Neuropathol. 2019 Nov;138(5):837-858. doi: 10.1007/s00401-019-02019-7. Epub 2019 Jun 14.
30 Prognostication after cardiac arrest: Results of an international, multi-professional survey.Resuscitation. 2019 May;138:190-197. doi: 10.1016/j.resuscitation.2019.03.016. Epub 2019 Mar 19.
31 A positive correlation between sickle cell anemia and g6pd deficiency from population of Chhattisgarh, India.Gene. 2019 Jul 30;707:143-150. doi: 10.1016/j.gene.2019.04.080. Epub 2019 May 7.
32 Relative Resilience of Cerebellar Purkinje Cells in a Cardiac Arrest/Resuscitation Rat Model.Neurocrit Care. 2020 Jun;32(3):775-789. doi: 10.1007/s12028-019-00799-0.
33 TNFSF/TNFRSF cytokine gene expression in sickle cell anemia: Up-regulated TNF-like cytokine 1A (TL1A) and its decoy receptor (DcR3) in peripheral blood mononuclear cells and plasma.Cytokine. 2019 Nov;123:154744. doi: 10.1016/j.cyto.2019.154744. Epub 2019 Jun 28.
34 Recovery from Coma Post-Cardiac Arrest Is Dependent on the Orexin Pathway.J Neurotrauma. 2017 Oct 1;34(19):2823-2832. doi: 10.1089/neu.2016.4852. Epub 2017 Jun 16.
35 Glucose Signaling Is Connected to Chromosome Segregation Through Protein Kinase A Phosphorylation of the Dam1 Kinetochore Subunit in Saccharomycescerevisiae.Genetics. 2019 Feb;211(2):531-547. doi: 10.1534/genetics.118.301727. Epub 2018 Dec 13.
36 Frequency of Interleukins IL1/IL18 and Inflammasome NLRP1/NLRP3 Polymorphisms in Sickle Cell Anemia Patients and their Association with Severity Score.Curr Mol Med. 2019;19(10):776-783. doi: 10.2174/1566524019666190826143749.
37 Roles of inositol 1,4,5-trisphosphate receptors in spinocerebellar ataxias.Neurochem Int. 2016 Mar;94:1-8. doi: 10.1016/j.neuint.2016.01.007. Epub 2016 Jan 28.
38 First de novo KCND3 mutation causes severe Kv4.3 channel dysfunction leading to early onset cerebellar ataxia, intellectual disability, oral apraxia and epilepsy.BMC Med Genet. 2015 Jul 21;16:51. doi: 10.1186/s12881-015-0200-3.
39 Andersen-Tawil syndrome: Clinical presentation and predictors of symptomatic arrhythmias - Possible role of polymorphisms K897T in KCNH2 and H558R in SCN5A gene.J Cardiol. 2017 Nov;70(5):504-510. doi: 10.1016/j.jjcc.2017.01.009. Epub 2017 Mar 21.
40 Genetic markers of repolarization and arrhythmic events after acute coronary syndromes.Am Heart J. 2015 Apr;169(4):579-86.e3. doi: 10.1016/j.ahj.2014.11.015. Epub 2014 Dec 11.
41 Confirmation of an association between the TNF(-308) promoter polymorphism and stroke risk in children with sickle cell anemia.Stroke. 2007 Aug;38(8):2241-6. doi: 10.1161/STROKEAHA.107.483115. Epub 2007 Jun 28.
42 The complement lectin pathway protein MAp19 and out-of-hospital cardiac arrest: Insights from two randomized clinical trials.Eur Heart J Acute Cardiovasc Care. 2020 Nov;9(4_suppl):S145-S152. doi: 10.1177/2048872619870031. Epub 2019 Sep 20.
43 A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemia.PLoS One. 2018 Jun 7;13(6):e0197927. doi: 10.1371/journal.pone.0197927. eCollection 2018.
44 Improving Patient Selection for Refractory Out of Hospital Cardiac Arrest Treated with Extracorporeal Life Support.Shock. 2018 Jan;49(1):24-28. doi: 10.1097/SHK.0000000000000941.
45 Repression of PLA2R1 by c-MYC and HIF-2alpha promotes cancer growth.Oncotarget. 2014 Feb 28;5(4):1004-13. doi: 10.18632/oncotarget.1681.
46 Genetic mutation in Korean patients of sudden cardiac arrest as a surrogating marker of idiopathic ventricular arrhythmia.J Korean Med Sci. 2013 Jul;28(7):1021-6. doi: 10.3346/jkms.2013.28.7.1021. Epub 2013 Jul 3.
47 Different subregional metabolism patterns in patients with cerebellar ataxia by 18F-fluorodeoxyglucose positron emission tomography.PLoS One. 2017 Mar 20;12(3):e0173275. doi: 10.1371/journal.pone.0173275. eCollection 2017.
48 Differential expression of somatostatin and dopamine receptor subtype genes in adrenocorticotropin (ACTH)-secreting pituitary tumors and silent corticotroph adenomas.Endocr J. 2009;56(4):579-84. doi: 10.1507/endocrj.k08e-186. Epub 2009 Mar 24.
49 Xuezhikang improves the outcomes of cardiopulmonary resuscitation in rats by suppressing the inflammation response through TLR4/NF-B pathway.Biomed Pharmacother. 2019 Jun;114:108817. doi: 10.1016/j.biopha.2019.108817. Epub 2019 Apr 4.
50 Discontinued stimulation of cardiomyocytes provides protection against hypothermia-rewarming-induced disruption of excitation-contraction coupling.Exp Physiol. 2018 Jun;103(6):819-826. doi: 10.1113/EP086774. Epub 2018 May 5.
51 Mild therapeutic hypothermia after out-of-hospital cardiac arrest: What does really matter?.Cardiol J. 2021;28(2):293-301. doi: 10.5603/CJ.a2019.0023. Epub 2019 Feb 25.
52 Uridine diphosphate glucuronosyl transferase 1A (UGT1A1) promoter polymorphism in young patients with sickle cell anaemia: report of the first cohort study from Nigeria.BMC Med Genet. 2019 Oct 16;20(1):160. doi: 10.1186/s12881-019-0899-3.
53 Emerging therapeutic targets in the short QT syndrome.Expert Opin Ther Targets. 2018 May;22(5):439-451. doi: 10.1080/14728222.2018.1470621.
54 Potential of lysophosphatidylinositol as a prognostic indicator of cardiac arrest using a rat model.Biomarkers. 2017 Dec;22(8):755-763. doi: 10.1080/1354750X.2016.1265002. Epub 2016 Dec 8.
55 Editor's Choice-Prospective registry of cardiac critical illness in a modern tertiary care Cardiac Intensive Care Unit.Eur Heart J Acute Cardiovasc Care. 2019 Dec;8(8):755-761. doi: 10.1177/2048872618789053. Epub 2018 Jul 23.
56 Improvement in Outcomes After Cardiac Arrest and Resuscitation by Inhibition of S-Nitrosoglutathione Reductase.Circulation. 2019 Feb 5;139(6):815-827. doi: 10.1161/CIRCULATIONAHA.117.032488.
57 Neurochemical profiles in hereditary ataxias: A meta-analysis of Magnetic Resonance Spectroscopy studies.Neurosci Biobehav Rev. 2020 Jan;108:854-865. doi: 10.1016/j.neubiorev.2019.12.019. Epub 2019 Dec 12.
58 Whole exome sequencing identifies a novel mutation in the transglutaminase 6 gene for spinocerebellar ataxia in a Chinese family.Clin Genet. 2013 Mar;83(3):269-73. doi: 10.1111/j.1399-0004.2012.01895.x. Epub 2012 May 29.
59 Effects of mTOR on Neurological Deficits after Transient Global Ischemia.Transl Neurosci. 2017 Apr 30;8:21-26. doi: 10.1515/tnsci-2017-0005. eCollection 2017.
60 The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients.PLoS One. 2013 Oct 30;8(10):e77681. doi: 10.1371/journal.pone.0077681. eCollection 2013.
61 Association of adenylyl cyclase 6 rs3730070 polymorphism and hemolytic level in patients with sickle cell anemia.Blood Cells Mol Dis. 2016 May;58:21-5. doi: 10.1016/j.bcmd.2016.02.006. Epub 2016 Feb 18.
62 Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes.Am J Hematol. 2013 Jul;88(7):571-6. doi: 10.1002/ajh.23457. Epub 2013 May 30.
63 Usefulness of neuron specific enolase in prognostication after cardiac arrest: Impact of age and time to ROSC.Resuscitation. 2019 Jun;139:214-221. doi: 10.1016/j.resuscitation.2019.04.021. Epub 2019 Apr 22.
64 Shaoyao Gancao Tang (SG-Tang), a formulated Chinese medicine, reduces aggregation and exerts neuroprotection in spinocerebellar ataxia type 17 (SCA17) cell and mouse models.Aging (Albany NY). 2019 Feb 13;11(3):986-1007. doi: 10.18632/aging.101804.
65 Spinocerebellar ataxia type 7: a neurodegenerative disorder with peripheral neuropathy.Eur Neurol. 2015;73(3-4):173-8. doi: 10.1159/000370239. Epub 2015 Jan 20.
66 Induction of protein inhibitor of neuronal nitric oxide synthase/cytoplasmic dynein light chain following cerebral ischemia.Neuroscience. 1998 May;84(1):81-8. doi: 10.1016/s0306-4522(97)00479-x.
67 A Novel Mutation in ELOVL4 Leading to Spinocerebellar Ataxia (SCA) With the Hot Cross Bun Sign but Lacking Erythrokeratodermia: A Broadened Spectrum of SCA34.JAMA Neurol. 2015 Jul;72(7):797-805. doi: 10.1001/jamaneurol.2015.0610.
68 Postanoxic alpha, theta or alpha-theta coma: Clinical setting and neurological outcome.Resuscitation. 2018 Mar;124:118-125. doi: 10.1016/j.resuscitation.2017.12.022. Epub 2017 Dec 22.
69 Novel PRKAG2 Variant Manifesting with a Cardiac Arrest in a Child.Pediatr Cardiol. 2020 Apr;41(4):843-845. doi: 10.1007/s00246-019-02245-6. Epub 2019 Nov 12.
70 Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nat Genet. 2010 Apr;42(4):313-21. doi: 10.1038/ng.544. Epub 2010 Mar 7.
71 Association of Rheumatoid Factors With Subclinical and Clinical Atherosclerosis in African American Women: The Multiethnic Study of Atherosclerosis.Arthritis Care Res (Hoboken). 2017 Feb;69(2):166-174. doi: 10.1002/acr.22930.
72 Mitochondrial Autophagy and NLRP3 Inflammasome in Pulmonary Tissues from Severe Combined Immunodeficient Mice after Cardiac Arrest and Cardiopulmonary Resuscitation.Chin Med J (Engl). 2018 May 20;131(10):1174-1184. doi: 10.4103/0366-6999.231519.
73 Asystole in alternating hemiplegia with de novo ATP1A3 mutation.Eur J Med Genet. 2014 Jan;57(1):37-9. doi: 10.1016/j.ejmg.2013.11.003. Epub 2013 Nov 28.
74 Olfactory Function in SCA10.Cerebellum. 2019 Feb;18(1):85-90. doi: 10.1007/s12311-018-0954-1.
75 Long-term effects of brief hypoxia due to cardiac arrest: Hippocampal reductions and memory deficits.Resuscitation. 2018 May;126:65-71. doi: 10.1016/j.resuscitation.2018.02.016. Epub 2018 Feb 21.
76 Calmodulin 2 Mutation N98S Is Associated with Unexplained Cardiac Arrest in Infants Due to Low Clinical Penetrance Electrical Disorders.PLoS One. 2016 Apr 21;11(4):e0153851. doi: 10.1371/journal.pone.0153851. eCollection 2016.
77 The CAPS Study: incidence, management and outcomes of cardiac arrest in pregnancy in the UK: a prospective, descriptive study.BJOG. 2017 Aug;124(9):1374-1381. doi: 10.1111/1471-0528.14521. Epub 2017 Feb 24.
78 Association of CASQ2 polymorphisms with sudden cardiac arrest and heart failure in patients with coronary artery disease.Heart Rhythm. 2014 Apr;11(4):646-52. doi: 10.1016/j.hrthm.2014.01.015. Epub 2014 Jan 17.
79 A Pentanucleotide ATTTC Repeat Insertion in the Non-coding Region of DAB1, Mapping to SCA37, Causes Spinocerebellar Ataxia. Am J Hum Genet. 2017 Jul 6;101(1):87-103. doi: 10.1016/j.ajhg.2017.06.007.
80 SCA38 is rare in Mainland China.J Neurol Sci. 2015 Nov 15;358(1-2):333-4. doi: 10.1016/j.jns.2015.09.350. Epub 2015 Sep 15.
81 Tapping CD4 T cells for cancer immunotherapy: the choice of personalized genomics.J Immunol. 2015 Mar 1;194(5):2049-56. doi: 10.4049/jimmunol.1402669.
82 DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases.Ann Neurol. 2016 Jun;79(6):983-90. doi: 10.1002/ana.24656. Epub 2016 May 6.
83 Development of phenotypic screening assays for -globin induction using primary human bone marrow day 7 erythroid progenitor cells.J Biomol Screen. 2013 Dec;18(10):1212-22. doi: 10.1177/1087057113499776. Epub 2013 Oct 25.
84 Sickle Cell Trait and Renal Function in Hispanics in the United States: The Northern Manhattan Study.Ethn Dis. 2017 Jan 19;27(1):11-14. doi: 10.18865/ed.27.1.11.
85 Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation.Nat Genet. 2010 Dec;42(12):1049-51. doi: 10.1038/ng.707. Epub 2010 Nov 7.
86 Next-generation sequencing study reveals the broader variant spectrum of hereditary spastic paraplegia and related phenotypes.Neurogenetics. 2019 Mar;20(1):27-38. doi: 10.1007/s10048-019-00565-6. Epub 2019 Feb 19.
87 Evaluation of genes encoding for the transient outward current (Ito) identifies the KCND2 gene as a cause of J-wave syndrome associated with sudden cardiac death.Circ Cardiovasc Genet. 2014 Dec;7(6):782-9. doi: 10.1161/CIRCGENETICS.114.000623. Epub 2014 Sep 11.
88 Cardiac Arrest Associated with Both an Anomalous Left Coronary Artery and KCNE1 Polymorphism.Int Heart J. 2019 Jul 27;60(4):1003-1005. doi: 10.1536/ihj.18-581. Epub 2019 Jul 12.
89 LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.J Exp Clin Cancer Res. 2019 Feb 21;38(1):95. doi: 10.1186/s13046-019-1092-4.
90 The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.Blood Cells Mol Dis. 2016 Nov;62:32-37. doi: 10.1016/j.bcmd.2016.11.002. Epub 2016 Nov 9.
91 Serum Bicarbonate Is Associated with Heart Failure in the Multi-Ethnic Study of Atherosclerosis.Am J Nephrol. 2017;45(2):118-126. doi: 10.1159/000454783. Epub 2016 Dec 10.
92 MTSS1/Src family kinase dysregulation underlies multiple inherited ataxias.Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12407-E12416. doi: 10.1073/pnas.1816177115. Epub 2018 Dec 7.
93 Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest.JAMA Neurol. 2019 Jan 1;76(1):64-71. doi: 10.1001/jamaneurol.2018.3223.
94 Can ambulance telephone triage using NHS Pathways accurately identify paediatric cardiac arrest?.Resuscitation. 2017 Jul;116:109-112. doi: 10.1016/j.resuscitation.2017.03.013. Epub 2017 Mar 16.
95 Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.World J Gastroenterol. 2015 Aug 7;21(29):8836-47. doi: 10.3748/wjg.v21.i29.8836.
96 PET and MRI detection of early and progressive neurodegeneration in spinocerebellar ataxia type 36.Mov Disord. 2017 Feb;32(2):264-273. doi: 10.1002/mds.26854. Epub 2016 Nov 10.
97 Mild hypothermia attenuates post-resuscitation brain injury through a V-ATPase mechanism in a rat model of cardiac arrest.Genet Mol Res. 2016 Jun 3;15(2). doi: 10.4238/gmr.15027729.
98 Identification and characterization of novel PDYN mutations in dominant cerebellar ataxia cases.J Neurol. 2013 Jul;260(7):1807-12. doi: 10.1007/s00415-013-6882-6. Epub 2013 Mar 8.
99 Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.J Pharmacol Exp Ther. 2013 Nov;347(2):516-28. doi: 10.1124/jpet.113.206888. Epub 2013 Sep 10.
100 Molecular genetic analysis of a new form of spinocerebellar ataxia in a Chinese Han family.Neurosci Lett. 2010 Aug 2;479(3):321-6. doi: 10.1016/j.neulet.2010.05.089.
101 Biallelic PPA2 Mutations Cause Sudden Unexpected Cardiac Arrest in Infancy.Am J Hum Genet. 2016 Sep 1;99(3):666-673. doi: 10.1016/j.ajhg.2016.06.021. Epub 2016 Aug 11.
102 Identification of the growth arrest and DNA damage protein GADD34 in the normal human heart and demonstration of alterations in expression following myocardial ischaemia.Int J Cardiol. 2006 Feb 8;107(1):126-9. doi: 10.1016/j.ijcard.2005.01.051.
103 SCA-LSVD: a repeat-oriented locus-specific variation database for genotype to phenotype correlations in spinocerebellar ataxias.Hum Mutat. 2009 Jul;30(7):1037-42. doi: 10.1002/humu.21006.
104 Identification of Ras-related nuclear protein, targeting protein for xenopus kinesin-like protein 2, and stearoyl-CoA desaturase 1 as promising cancer targets from an RNAi-based screen.Cancer Res. 2007 May 1;67(9):4390-8. doi: 10.1158/0008-5472.CAN-06-4132.
105 Prevalence and correlates of metabolic acidosis among patients with homozygous sickle cell disease.Clin J Am Soc Nephrol. 2014 Apr;9(4):648-53. doi: 10.2215/CJN.09790913. Epub 2014 Jan 23.
106 Epidermal growth factor receptor-related protein: a potential therapeutic agent for colorectal cancer.Gastroenterology. 2003 May;124(5):1337-47. doi: 10.1016/s0016-5085(03)00264-6.
107 Semaphorin 3F Promotes Transendothelial Migration of Leukocytes in the Inflammatory Response After Survived Cardiac Arrest.Inflammation. 2019 Aug;42(4):1252-1264. doi: 10.1007/s10753-019-00985-4.
108 Multimodal Outcome Prognostication After Cardiac Arrest and Targeted Temperature Management: Analysis at 36C.Neurocrit Care. 2018 Feb;28(1):104-109. doi: 10.1007/s12028-017-0393-8.
109 Spinocerebellar ataxia.Nat Rev Dis Primers. 2019 Apr 11;5(1):24. doi: 10.1038/s41572-019-0074-3.
110 Derivation and Validation of the CREST Model for Very Early Prediction of Circulatory Etiology Death in Patients Without ST-Segment-Elevation Myocardial Infarction After Cardiac Arrest.Circulation. 2018 Jan 16;137(3):273-282. doi: 10.1161/CIRCULATIONAHA.116.024332. Epub 2017 Oct 26.
111 Cerebellar cognitive-affective syndrome preceding ataxia associated with complex extrapyramidal features in a Turkish SCA48 family.Neurogenetics. 2020 Jan;21(1):51-58. doi: 10.1007/s10048-019-00595-0. Epub 2019 Nov 19.
112 Generation of a neurodegenerative disease mouse model using lentiviral vectors carrying an enhanced synapsin I promoter.J Neurosci Methods. 2014 Feb 15;223:133-43. doi: 10.1016/j.jneumeth.2013.12.004. Epub 2013 Dec 19.
113 International Triadin Knockout Syndrome Registry. Circ Genom Precis Med. 2019 Feb;12(2):e002419. doi: 10.1161/CIRCGEN.118.002419.
114 Spinocerebellar ataxia type 11 in the Chinese Han population.Neurol Sci. 2010 Feb;31(1):107-9. doi: 10.1007/s10072-009-0129-4. Epub 2009 Sep 19.